Bio-Nanomedicine for Cancer Therapy

Flavia Fontana, Hélder A. Santos (Herausgeber)

Buch | Softcover

VIII, 360 Seiten

2022 | 1st ed. 2021
Springer International Publishing (Verlag)
978-3-030-58176-3 (ISBN)

Artikel merken

The book covers the latest developments in biologically-inspired and derived nanomedicine for cancer therapy. The purpose of the book is to illustrate the significance of naturally-mimicking systems for enhancing the dose delivered to the tumor, to improve stability, and prolong the circulation time. Moreover, readers are presented with advanced materials such as adjuvants for immunostimulation in cancer vaccines. The book also provides a comprehensive overview of the current status of academic research. This is an ideal book for students, researchers, and professors working in nanotechnology, cancer, targeted drug delivery, controlled drug release, materials science, and biomaterials as well as companies developing cancer immunotherapy.

Hélder A. Santos is a Full Professor in Pharmaceutical Nanotechnology, Principal Investigator/Group Leader, Director of the Doctoral Program in Drug Research, and Head of the Nanomedicines and Biomedical Engineering Group at the Faculty of Pharmacy, University of Helsinki (Finland). He is also the Director of the FinPharmNet and Chair of Controlled Release Society Focus Group in Nanomedicine and Nanoscale Delivery. Prof. Santos' research is focused on nanobiomaterials, nanovaccines, inorganic and and polymeric-based nanomedicines for controlled drug delivery, diagnostics and therapy. The research interests include the development of nanomedicines for biomedical and healthcare applications. His current work makes the bridge between engineering, pharmaceutical and medical research. His main research focus is in the use of biodegradable and biocompatible nanomaterials for simultaneous controlled drug delivery, diagnostic and treatment of cancer, diabetes, and cardiovascular diseases, and ^ 8800 citations, h-index = 56), and more than 260 conference proceedings/abstracts.

Part 1.- Conventional nanosized drug delivery systems for cancer applications.- Homing peptides for cancer therapy.- Radiolabeling of theranostic nanosystems.- Boosting nanomedicine efficacy with hyperbaric oxygen therapy.- Part 2.- Mesoporous Silica Nanoparticles as Carriers for Biomolecules in Cancer Therapy.- Clearable Nanoparticles for Cancer Photothermal Therapy.- Biohybrid Nanosystems for Cancer Treatment: Merging the Best of Two Worlds.- Electrospun Nanofibers for Cancer Therapy.- Nanoneedle-based materials for intracellular studies.- Part 3.- In vitro assays for nanoparticle-cancer cell interaction studies.- 3D tumor spheroid models for in vitro therapeutic screening of nanoparticles.- In vitro and in vivo tumor models for the evaluation of anticancer nanoparticles.- Part 4.- Nanotechnology for the Development of Nanovaccines in Cancer Immunotherapy.- Viral nanoparticles: cancer vaccines and immune modulators.- Industrial Perspective on Cancer Immunotherapy.- Index.

Erscheinungsdatum	06.02.2022
Reihe/Serie	Advances in Experimental Medicine and Biology
Zusatzinfo	VIII, 360 p. 80 illus. in color.
Verlagsort	Cham
Sprache	englisch
Maße	210 x 279 mm
Gewicht	906 g
Themenwelt	Medizin / Pharmazie ► Medizinische Fachgebiete ► Onkologie
	Medizin / Pharmazie ► Physiotherapie / Ergotherapie ► Orthopädie
	Naturwissenschaften ► Biologie ► Genetik / Molekularbiologie
	Technik ► Umwelttechnik / Biotechnologie
Schlagworte	Biohybrid • Cancer Nanotechnology • Drug delivery systems nanotechnology • nanotechnology • Vaccines nantechnology
ISBN-10	3-030-58176-4 / 3030581764
ISBN-13	978-3-030-58176-3 / 9783030581763
Zustand	Neuware